Skip to content

Zymeworks ZYME Taxes Paid

Taxes Paid at other companies

Septerna, Inc. logo
Septerna, Inc.SEPN
$0
Maze Therapeutics, Inc. Common Stock logo
Maze Therapeutics, Inc. Common StockMAZE
$307.5K
TG Therapeutics logo
TG TherapeuticsTGTX
$3.44M
Innoviva, Inc. logo
Innoviva, Inc.INVA
$670K
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
$774K+176%
TEC
Bio-TechneTECH

Other financials

Income statement

See full
Revenue$2.4M-91.1%
Operating income-$47.1M-84.0%
Net income-$44.2M-95.1%
EPS (diluted)-$0.59-96.7%

Balance sheet

See full
Cash & equivalents$244.3M+221%
Total debt$17.0M-7.7%
Total equity$163.6M-49.7%
Total assets$478.2M+12.4%

Cash flow

See full
Operating cash flow-$45.7M-1,242%
CapEx$216.0K+1,250%
Free cash flow-$45.9M-1,242%

Valuation

See full
Market cap$1.79B+125%

Profitability

See full
Operating margin-140.4%+7.3pp
Net margin-126.3%+5.0pp
FCF margin-94.8%+15.5pp

Returns & leverage

See full
Return on equity-42%+29.2pp
Debt / equity0.1×0.0×
Current ratio10.8×+6.1×

Where this comes from

Reported directly by Zymeworks in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxesPaidNet.

The official record: Zymeworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zymeworks's taxes paid.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Zymeworks's taxes paid?
Zymeworks (ZYME) reported taxes paid of $245K in Q1 2026.
How has Zymeworks's taxes paid changed year-over-year?
Zymeworks's taxes paid decreased by 36.7% year-over-year, from $387K to $245K.
What is the long-term trend for Zymeworks's taxes paid?
Over 3 years (2022 to 2025), Zymeworks's taxes paid has grown at a -48.7% compound annual growth rate (CAGR), from $10M to $1.35M.
What does taxes paid mean?
Actual cash paid to tax authorities for income taxes during the period — may differ from income tax expense due to timing.